Oscar Health, Inc. 8-K

What Happened

• Oscar Health, Inc. (OSCR) filed a Form 8-K on March 2, 2026 reporting that the company participated in the 2026 Raymond James Institutional Investors Conference on March 2, 2026 and reaffirmed the full‑year 2026 guidance it previously provided in its February 10, 2026 press release covering fourth‑quarter and full‑year 2025 results. The disclosure was made under Item 7.01 (Regulation FD Disclosure).
• The filing includes a standard cautionary note that the statements are forward‑looking, subject to risks and uncertainties, and refers investors to the “Risk Factors” in Oscar’s Form 10‑K for the year ended December 31, 2025.

Key Details

• Event: 2026 Raymond James Institutional Investors Conference on March 2, 2026.
• Action: Company reaffirmed its full‑year 2026 guidance originally issued in the February 10, 2026 press release.
• Filing: Form 8‑K under Item 7.01 filed March 2, 2026; disclosure is not deemed “filed” for purposes of Section 18 of the Exchange Act or incorporated by reference unless explicitly stated.
• Forward‑looking statements: Company warns statements are predictions, subject to risks described in its 2025 Form 10‑K.

Why It Matters

• For investors, reaffirmation of guidance provides management’s current expectations for 2026 and helps set near‑term performance benchmarks tied to earnings and revenue outlooks.
• The filing also reminds investors that guidance is forward‑looking and subject to change; the company points to its 2025 10‑K risk factors as potential causes for deviations from the stated guidance.